JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.76% |
| 2 | Technology | 12.42% |
| 3 | Healthcare | 9.53% |
| 4 | Consumer Discretionary | 8.53% |
| 5 | Industrials | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Scorpio Tankers
STNG
$3.93B
| $187K | ﹤0.01% |
6,601
+708
| +12% | +$18.9K |
|
4402
Intellia Therapeutics
NTLA
$1.66B
| $185K | ﹤0.01% |
6,748
-21,136
| -76% | -$512K |
|
4403
AtriCure
ATRC
$2.21B
| $184K | ﹤0.01% |
6,809
-7,399
| -52% | -$174K |
|
4404
AppFolio
APPF
$7.22B
| $183K | ﹤0.01% |
2,997
-6,526
| -69% | -$356K |
|
|
PNTR
4405
DELISTED
Pointer Telocation Ltd.
PNTR
| $183K | ﹤0.01% |
15,228
+10,507
| +223% | +$146K |
|
|
ECYT
4406
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $183K | ﹤0.01% |
+13,298
| New | +$158K |
|
|
SAFE
4407
DELISTED
Safehold Inc.
SAFE
| $183K | ﹤0.01% |
9,642
-99,813
| -91% | -$1.81M |
|
4408
Cerus
CERS
$572M
| $182K | ﹤0.01% |
27,295
-299,302
| -92% | -$1.84M |
|
4409
NRC Health Common Stock
NRC
$471M
| $182K | ﹤0.01% |
4,852
+2,865
| +144% | +$99.8K |
|
4410
Ovid Therapeutics
OVID
$523M
| $181K | ﹤0.01% |
23,145
-9,861
| -30% | -$84.6K |
|
4411
PUT
Vanguard Information Technology ETF
VGT
$151B
| $181K | ﹤0.01% |
+8,000
| New | +$180K |
|
4412
PUT
Viatris
VTRS
$18.4B
| $181K | ﹤0.01% |
5,000
-170,000
| -97% | -$6.67M |
|
|
MRTX
4413
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $181K | ﹤0.01% |
+3,678
| New | +$139K |
|
4414
Superior Group of Companies
SGC
$210M
| $180K | ﹤0.01% |
8,699
+6,982
| +407% | +$170K |
|
|
NCOM
4415
DELISTED
National Commerce Corporation
NCOM
| $180K | ﹤0.01% |
3,897
-311
| -7% | -$14.2K |
|
4416
Cass Information Systems
CASS
$750M
| $179K | ﹤0.01% |
3,116
+19
| +0.6% | +$998 |
|
|
PAMT
4417
PAMT Corp
PAMT
$285M
| $179K | ﹤0.01% |
15,240
-7,884
| -34% | -$78.3K |
|
|
ODT
4418
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $179K | ﹤0.01% |
8,108
+6,746
| +495% | +$157K |
|
|
REN
4419
DELISTED
Resolute Energy Corporaton
REN
| $179K | ﹤0.01% |
5,724
-2,502
| -30% | -$83K |
|
|
CFRX
4420
DELISTED
ContraFect Corporation
CFRX
| $178K | ﹤0.01% |
100
-3
| -3% | -$4.42K |
|
4421
Brown-Forman Class A
BF.A
$13.1B
| $177K | ﹤0.01% |
3,634
+2,486
| +217% | +$132K |
|
4422
Data I/O
DAIO
$33.1M
| $176K | ﹤0.01% |
+27,699
| New | +$196K |
|
4423
CapForce IBD 50 ETF
FFTY
$80.5M
| $175K | ﹤0.01% |
4,984
| – | – |
|
4424
State Street Global Allocation ETF
GAL
$316M
| $175K | ﹤0.01% |
4,632
+195
| +4% | +$7.47K |
|
4425
Origin Bancorp
OBK
$1.69B
| $175K | ﹤0.01% |
+4,266
| New | +$166K |
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.